Theme

Reimbursement for medicine

Read about how much you can get in reimbursement for your medicine, which types of reimbursement you can get in Denmark, and what the rules are for the different types of reimbursement.

Go to theme
Theme

Strategy for the DKMA

The Danish Medicines Agency has formulated a strategy for 2022-26. The strategy emphasizes a vision of leading the way in national and international cooperation, and in the dialogue with citizens and society. Read more.

Go to theme
indgangsikon nr 1

General public

Here you can read about reimbursement, drugs affecting the ability to drive and other topics relevant for the general public.

indgangsikon nr 2

Industry

Information on licensing, inspections, fees, company authorisations, clinical trials and more.

indgangsikon nr 3

Healthcare professionals

This section gathers information for doctors, nurses, pharmacies, dentists and other healthcare professionals.

Report a side effect from medicines About Brexit International activities Transparency Subscribe to news in English Mission, vision and strategy Whistleblower scheme New veterinary medicinal products regulation Jobs 0

News

Suspicion of rare eye condition from Ozempic use to be investigated further

16 December 2024

The Danish Medicines Agency will request the European Pharmacovigilance Risk Assessment Commit-tee, PRAC, to assess two new Danish register-based studies from the University of Southern Denmark. The studies point to a potential increased risk of a rare eye condition, NAION, in patients receiving the diabetes medicine Ozempic.

Suspicion of rare eye condition from Ozempic use to be investigated further

16 December 2024

2024 deadline for submitting applications concerning marketing authorisations and clinical trials

05 November 2024

Nyt lægemiddel tilføjet listen over kritiske lægemidler med forsyningsproblemer

09 December 2024